ige increas autoantibodi format mice mercur chlorid previou studi suscept mous strain a.sw inject subtox dose induc serum level total ige high serum titer antinuclear autoantibodi immune-complex glomerulonephr suscept Th cell induct immunopatholog alter present studi treatment vivo mab increas total ige increas increas pattern igg subclass distribut mice wherea treatment mab titer anola anola result contribut optim format vivo murin autoantibodi format system autoimmun diseas avail evid increas product cell correct mhc class II preferenti respons cell type immunopatholog alter 